HealthEquity, Inc.
NASDAQ:HQYMedical - Healthcare Information Services
-$0.54 today
- Market cap
- $8.05B
- Beta
- 0.21
- P/E (TTM)
- 31.4
- EPS (TTM)
- $2.73
Volume 1.29M
Average 0.98M
HQY Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
HealthEquity, Inc.NASDAQ: HQY
Net Margin · Q2 FY2027 · quarter ended Jul 2026
Net margin holds steady near 18.7%
Net margin was 18.7% in Q2 FY2027, up 0.3 pp from a year earlier. On a trailing-twelve-month basis it was 17.4%, up 5.9 pp year over year. Over 3 fiscal years it widened by 19.4 pp.
Context
- Net margin widened in 3 of the last 3 fiscal years.
- FY2026 was the highest level in the 4 fiscal years shown.
What to watch
Whether net margin reaches the consensus estimate from 11 analysts of 29.2% for the fiscal year ending Jan 2027, up from 16.4% in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJul 2026
- 18.7%-0.9 pp QoQ
- Last fiscal yearJan 2026
- 16.4%+8.3 pp YoY
- LTMJul 2026
- 17.4%+5.9 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +0.3 pp | +12.2 pp | +11.9 pp |
| 1 year | +8.3 pp | +12.8 pp | +4.5 pp |
| 3 years | +19.4 pp | +13.4 pp | -6.0 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2026
- 16.4%
- Year-over-year change
- +8.3pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 16.4% | +8.3pp |
| FY2025 | 2025-01-31 | 8.1% | +2.5pp |
| FY2024 | 2024-01-31 | 5.6% | +8.6pp |
| FY2023 | 2023-01-31 | -3.0% | +2.8pp |
| FY2022 | 2022-01-31 | -5.9% | — |
Net Margin vs competitors
How HQY compares with its peers on the latest reported figures
- HQY's LTM Jul 2026 net margin of 17.4% is the highest of the 8 companies compared; the peer median is 1.7%.
- Its year-over-year change of +5.9 pp is the 5th highest of 8, against a peer median of +11.7 pp.
- Over three fiscal years its change of +19.4 pp compares with a peer median of +23.6 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jul 2026 | 17.4% | +5.9 pp | +19.4 pp | |
| LTM Jun 2026 | 11.2% | +2.7 pp | +17.5 pp | |
| LTM Mar 2026 | 7.9% | -1.1 pp | +5.0 pp | |
| LTM Apr 2026 | 1.9% | +11.7 pp | +63.2 pp | |
| LTM Mar 2026 | 1.7% | -0.2 pp | -0.3 pp | |
| LTM Mar 2026 | -2.2% | +17.6 pp | +76.4 pp | |
CTEVClaritev Corporation | LTM Mar 2026 | -29.3% | +97.7 pp | +23.6 pp |
| LTM Mar 2026 | -37.0% | +22.1 pp | +59.2 pp | |
| Peer median (excluding HQY) | 1.7% | +11.7 pp | +23.6 pp | |
Competitors are the stored peer set for HQY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 756.56M | 861.75M | 999.59M | 1.2B | 1.31B |
| Cost of Revenue | 415.64M | 466.24M | 469.71M | 507.19M | 400.31M |
| Gross Profit | 340.92M | 395.51M | 529.87M | 692.58M | 913.12M |
| Gross Margin | 45.1% | 45.9% | 53.0% | 57.7% | 69.5% |
| Research & Development | 157.36M | 193.38M | 218.81M | 239.51M | 262.51M |
| Selling, General & Admin | 142.98M | 164.48M | 182.93M | 223M | 328.15M |
| Operating Expenses | 300.35M | 357.85M | 401.74M | 462.51M | 590.66M |
| Depreciation & Amortization | 137.19M | 161.2M | 153.08M | 162.45M | 154.66M |
| EBITDA | 102.97M | 171.53M | 282.42M | 337.54M | 489.22M |
| EBITDA Margin | 13.6% | 19.9% | 28.3% | 28.1% | 37.2% |
| Operating Income | 40.57M | 37.65M | 128.13M | 230.07M | 322.46M |
| Operating Margin | 5.4% | 4.4% | 12.8% | 19.2% | 24.6% |
| Interest Income | 1.5M | 1.76M | 12.14M | 13.91M | 12.11M |
| Interest Expense | 36.57M | 48.42M | 55.46M | 60.63M | 57.13M |
| Other Income / Expenses | (107.31M) | (75.75M) | (53.09M) | (114.04M) | (45.02M) |
| Income Before Tax | (66.74M) | (38.1M) | 75.04M | 116.03M | 277.43M |
| Pre-Tax Margin | -8.8% | -4.4% | 7.5% | 9.7% | 21.1% |
| Income Tax Expense | (22.45M) | (11.95M) | 19.33M | 19.33M | 62.23M |
| Net Income | (44.29M) | (26.14M) | 55.71M | 96.7M | 215.2M |
| Net Margin | -5.9% | -3.0% | 5.6% | 8.1% | 16.4% |
| EPS (Basic) | (0.53) | (0.31) | 0.65 | 1.11 | 2.50 |
| EPS (Diluted) | (0.53) | (0.31) | 0.64 | 1.09 | 2.46 |
| Weighted Avg Shares | 83.13M | 84.44M | 85.56M | 86.87M | 86.13M |
| Weighted Avg Shares (Diluted) | 83.13M | 84.44M | 86.96M | 88.83M | 87.47M |
HealthEquity, Inc.
NASDAQ:HQY
Intrinsic Alpha fair value
Locked
Current Price
$97.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.